219 related articles for article (PubMed ID: 30451116)
1. Cucurbitacins as Anticancer Agents: A Patent Review.
Hussain H; Green IR; Saleem M; Khattak KF; Irshad M; Ali M
Recent Pat Anticancer Drug Discov; 2019; 14(2):133-143. PubMed ID: 30451116
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of boswellic acids: a patent review (1990-2015).
Hussain H; Al-Harrasi A; Csuk R; Shamraiz U; Green IR; Ahmed I; Khan IA; Ali Z
Expert Opin Ther Pat; 2017 Jan; 27(1):81-90. PubMed ID: 27646163
[TBL] [Abstract][Full Text] [Related]
3. Cucurbitacins: A Systematic Review of the Phytochemistry and Anticancer Activity.
Cai Y; Fang X; He C; Li P; Xiao F; Wang Y; Chen M
Am J Chin Med; 2015; 43(7):1331-50. PubMed ID: 26503558
[TBL] [Abstract][Full Text] [Related]
4. Potential of cucurbitacin as an anticancer drug.
Li Y; Li Y; Yao Y; Li H; Gao C; Sun C; Zhuang J
Biomed Pharmacother; 2023 Dec; 168():115707. PubMed ID: 37862969
[TBL] [Abstract][Full Text] [Related]
5. Ursolic acid derivatives for pharmaceutical use: a patent review (2012-2016).
Hussain H; Green IR; Ali I; Khan IA; Ali Z; Al-Sadi AM; Ahmed I
Expert Opin Ther Pat; 2017 Sep; 27(9):1061-1072. PubMed ID: 28637397
[TBL] [Abstract][Full Text] [Related]
6. Cucurbitacins as inducers of cell death and a rich source of potential anticancer compounds.
Ríos JL; Andújar I; Escandell JM; Giner RM; Recio MC
Curr Pharm Des; 2012; 18(12):1663-76. PubMed ID: 22443631
[TBL] [Abstract][Full Text] [Related]
7. A patent review of the therapeutic potential of isoflavones (2012-2016).
Hussain H; Green IR
Expert Opin Ther Pat; 2017 Oct; 27(10):1135-1146. PubMed ID: 28586284
[TBL] [Abstract][Full Text] [Related]
8. Biological activities and potential molecular targets of cucurbitacins: a focus on cancer.
Chen X; Bao J; Guo J; Ding Q; Lu J; Huang M; Wang Y
Anticancer Drugs; 2012 Sep; 23(8):777-87. PubMed ID: 22561419
[TBL] [Abstract][Full Text] [Related]
9. Lapachol and lapachone analogs: a journey of two decades of patent research(1997-2016).
Hussain H; Green IR
Expert Opin Ther Pat; 2017 Oct; 27(10):1111-1121. PubMed ID: 28586252
[TBL] [Abstract][Full Text] [Related]
10. Cucurbitacins as potential anticancer agents: new insights on molecular mechanisms.
Varela C; Melim C; Neves BG; Sharifi-Rad J; Calina D; Mamurova A; Cabral C
J Transl Med; 2022 Dec; 20(1):630. PubMed ID: 36585670
[TBL] [Abstract][Full Text] [Related]
11. A patent review of two fruitful decades (1997-2016) of Isocoumarin research.
Hussain H; Green IR
Expert Opin Ther Pat; 2017 Nov; 27(11):1267-1275. PubMed ID: 28621561
[TBL] [Abstract][Full Text] [Related]
12. Cucurbitacins and the Immune System: Update in Research on Anti- inflammatory, Antioxidant, and Immunomodulatory Mechanisms.
Silvestre GFG; de Lucena RP; da Silva Alves H
Curr Med Chem; 2022; 29(21):3774-3789. PubMed ID: 34994307
[TBL] [Abstract][Full Text] [Related]
13. Cucurbitacins from the Leaves of Citrullus colocynthis (L.) Schrad.
Chawech R; Jarraya R; Girardi C; Vansteelandt M; Marti G; Nasri I; Racaud-Sultan C; Fabre N
Molecules; 2015 Sep; 20(10):18001-15. PubMed ID: 26437392
[TBL] [Abstract][Full Text] [Related]
14. Use of cucurbitacins for lung cancer research and therapy.
Liu M; Yan Q; Peng B; Cai Y; Zeng S; Xu Z; Yan Y; Gong Z
Cancer Chemother Pharmacol; 2021 Jul; 88(1):1-14. PubMed ID: 33825035
[TBL] [Abstract][Full Text] [Related]
15. Isolation of anticancer constituents from Cucumis prophetarum var. prophetarum through bioassay-guided fractionation.
Alsayari A; Kopel L; Ahmed MS; Soliman HSM; Annadurai S; Halaweish FT
BMC Complement Altern Med; 2018 Oct; 18(1):274. PubMed ID: 30301463
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic and antimetastatic effect of cucurbitacins in cancer: recent trends and advancement.
Kumar A; Sharma B; Sharma U; Parashar G; Parashar NC; Rani I; Ramniwas S; Kaur S; Haque S; Tuli HS
Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):1867-1878. PubMed ID: 37010571
[TBL] [Abstract][Full Text] [Related]
17. Dammarane triterpenoids for pharmaceutical use: a patent review (2005 - 2014).
Cao J; Zhang X; Qu F; Guo Z; Zhao Y
Expert Opin Ther Pat; 2015 Jul; 25(7):805-17. PubMed ID: 25892194
[TBL] [Abstract][Full Text] [Related]
18. Journey Describing the Cytotoxic Potential of Withanolides: A Patent Review.
Hussain H; Csuk R; Green IR; Ur Rehman N; Abbas G; Hussain W
Recent Pat Anticancer Drug Discov; 2018; 13(4):411-421. PubMed ID: 30091418
[TBL] [Abstract][Full Text] [Related]
19. Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent Trends.
Tuli HS; Rath P; Chauhan A; Ranjan A; Ramniwas S; Sak K; Aggarwal D; Kumar M; Dhama K; Lee EHC; Yap KC; Capinpin SM; Kumar AP
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671442
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of glycyrrhetinic acids: a patent review (2010-2017).
Hussain H; Green IR; Shamraiz U; Saleem M; Badshah A; Abbas G; Rehman NU; Irshad M
Expert Opin Ther Pat; 2018 May; 28(5):383-398. PubMed ID: 29558289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]